New product: Bijuve 1mg/100mg Capsules, soft (estradiol, progesterone)
This oral continuous combined hormone replacement therapy (HRT) product is licensed for the treatment of estrogen deficiency symptoms in postmenopausal women with an intact uterus and with at least 12 months since their last menses.
Source:
electronic Medicines compendium
SPS commentary:
Bijuve is a combination of estradiol and progesterone, both of which are chemically and biologically identical to the endogenous human hormones. It is the first oral continuous combined body-identical estradiol/progesterone formulation to be available in the UK.